Sysmex (6869) · InitiativeAchieved
Strengthening Diagnostic Reagent Production Capabilities Through the Absorption-Type Merger of Sysmex International Reagents
First written in FY2022-Q2. 1 of 2 entries say "Achieved", first in FY2022. Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Strengthening the Manufacturing and Supply Structure Through the Establishment and Integration of a Production CompanyA theme 3 companies write about · 0 as a headwind · 3 as a tailwind
0 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022AchievedAnnual report
「At a meeting of the Board of Directors held on 21 September 2021, the company resolved to absorb and merge its wholly owned subsidiary Sysmex International Reagents Co., Ltd., and completed the merger effective 1 April 2022.」
The absorption-type merger of Sysmex International Reagents was implemented and completed effective 1 April 2022. It aimed to strengthen corporate functions related to diagnostics production and improve efficiency and productivity. - FY2022-Q2First statedAnnual report
「Sysmex International Reagents manufactures reagents for in vitro diagnostics. The company will carry out this merger to strengthen the corporate functions related to diagnostics production within the group and improve efficiency and productivity. Effective date of merger: 1 April 2022 (scheduled)」
The company entered into an agreement to absorb and merge its wholly owned subsidiary Sysmex International Reagents effective 1 April 2022. The merger aims to strengthen corporate functions related to diagnostics production and improve efficiency and productivity.